Congo vs Niger: Treatment coverage for schistosomiasis
Congo
37.0%
in 2023
Niger
35.1%
in 2024
Congo rank
33rd
Niger rank
36th
Treatment coverage for schistosomiasis over time
- Congo
- Niger
How they compare
Congo currently reports 37.0% against 35.1% in Niger, a difference of 1.9%.
That makes Congo's figure about 1.1 times Niger's.
The two have swapped places 2 times across 7 shared years of data; in 2014 it was Niger ahead.
Congo ranks 33rd and Niger ranks 36th of 45 countries.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 32.6% | 81.6% | 49.0% | Niger |
| 2020s | 23.1% | 47.5% | 24.4% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Congo or Niger?
- Congo, at 37.0% against 35.1% in Niger as of 2023.
- What is the difference in treatment coverage for schistosomiasis between Congo and Niger?
- 1.9%, with Congo ahead.
- How many years of comparable data are there for Congo and Niger?
- 7 years are reported by both, from 2014 to 2023.
- How do Congo and Niger rank globally for treatment coverage for schistosomiasis?
- Congo ranks 33rd and Niger ranks 36th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.